Sanford Health is continuing to explore the potential of orthobiologics and regenerative medicine with a study that may advance treatment for those living with osteoarthritis. This trial known as ENDURE, which is run in full compliance with the FDA, will examine the safety and effectiveness of adult, adipose (fat)-derived stem cells. Im really excited to get the trial started, said Donella Herman, M.D., a specialist in sports medicine at Sanford Health.
Researchers at Yale and the Weizmann Institute of Science have found the first evidence that the human fetus can spontaneously produce insulin outside the pancreas in the small intestine, specifically a startling discovery that stands in contrast to the longheld belief that insulin production is unique to the pancreas.
Tanmay Mathur observes a vascular organ-on-a-chip made from blood cells under a microscope. Texas A&M Engineering Organ-on-a-chip technology has provided a push to discover new drugs for a variety of rare and ignored diseases for which current models either dont exist or lack precision
GAITHERSBURG, Md., Dec. 10, 2021 /PRNewswire/ -- Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and enabling access to cures for all patients, everywhere, announced today that Nature Communications has published a scientific manuscript highlighting research demonstrating the effectiveness of place-of-care manufacturing of anti-CD19 CAR T cells for treatment of B-cell malignancies
Event summary produced by The Globe and Mail Events team. The Globes editorial department was not involved.
How the body uses fat to fight infection New research from the University of East Anglia and Quadram Institute reveals how our immune cells use the bodys fat stores to fight infection. The research, published today in the journal Nature Communications, could help develop new approaches to treating people with bacterial infections.
"California Cloning: A Dialogue on State Regulation" was convened October 12, 2001, by the Markkula Center for Applied Ethics at Santa Clara University. Its purpose was to bring together experts from the fields of science, religion, ethics, and law to discuss how the state of California should proceed in regulating human cloning and stem cell research. A framework for discussing the issue was provided by Center Director of Biotechnology and Health Care Ethics Margaret McLean, who also serves on the California State Advisory Committee on Human Cloning.
Post Date: 04/2005, Updated 08/2009Author: CBHD Research Staff In November of 1998, scientists reported that they had successfully isolated and cultured human embryonic stem cellsa feat which had eluded researchers for almost two decades. This announcement kicked off an intense and unrelenting debate between those who approve of embryonic stem cell research and those who are opposed to it. Some of the most prominent advocates of the research are scientists and patients who believe that embryonic stem cell research will lead to the development of treatments and cures for some of humanitys most pernicious afflictions (such as Alzheimers disease, Parkinsons disease, heart disease, and diabetes)
Dublin, Dec. 03, 2021 (GLOBE NEWSWIRE) -- The "Global Research Antibodies Market Size, Share & Trends Analysis Report by Product (Primary, Secondary), by Type (Monoclonal Antibodies, Polyclonal Antibodies), by Technology, by Source, by Application, by End-use, by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
Frequently Asked Questions Michigan Law and President Obamas Executive Order Embryonic, Adult, and IPS (induced Pluripotent) Stem Cells Benefits of Stem Cell Research Embryo and Fetus Definitions Cloning Public Opinions Ethics Federally Approved Stem Cell Lines Stem Cells: Myth Vs.
Recent Comments